Targeted Drug Delivery To Leukocytes with ICAM-1 Derived Peptides
View/ Open
Issue Date
2008-07-15Author
Majumdar, Sumit
Publisher
University of Kansas
Format
185 pages
Type
Dissertation
Degree Level
PH.D.
Discipline
Pharmaceutical Chemistry
Rights
This item is protected by copyright and unless otherwise specified the copyright of this thesis/dissertation is held by the author.
Metadata
Show full item recordAbstract
Intercellular adhesion molecule-1 (ICAM-1) derived cyclic peptide cIBR [cyclo(1,12)PenPRGGSVLVTGC] showed high affinity for leukocyte function associated antigen-1 (LFA-1) receptor and was internalized into the MOLT-3 T-cells. Therefore, the objective of the dissertation was to explore the possibility of selectively delivering drugs to leukocytes using ICAM-1 derived peptides. Fluorescein isothiocyanate conjugated cIBR (FITC-cIBR) and doxorubicin conjugated cIBR (DOX-cIBR) entered the HL-60 cells by receptor mediated endocytosis and passive diffusion, respectively. High hydrophobicity of DOX-cIBR was proposed to be responsible for its energy-independent entry (chapter 2). To check the effect of hydrophobicity on internalization, two relatively more hydrophilic cIBR-derived peptides were conjugated to DOX. However, both the DOX-peptide conjugates were internalized passively (chapter 3). Degradation mechanism of methotrexate conjugate of cIBR (MTX-cIBR) was studied and suitable formulation conditions were developed. Stability of MTX-cIBR was assessed with in vitro biological matrices to determine optimum dosing regimen for in vivo studies (chapter 4).
Collections
Items in KU ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
We want to hear from you! Please share your stories about how Open Access to this item benefits YOU.